comparemela.com

பால் பார்மா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bal Pharma Ltd Q1FY22 consolidated PAT at Rs 1 64 crore

Bal Pharma Ltd Q1FY22 consolidated PAT at Rs 1 64 crore
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Bal Pharma reports consolidated net profit of Rs 3 58 crore in the March 2021 quarter

Bal Pharma reports consolidated net profit of Rs 3 58 crore in the March 2021 quarter
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Bal Pharma reports standalone net profit of Rs 4 38 crore in the March 2021 quarter

Bal Pharma reports standalone net profit of Rs 4 38 crore in the March 2021 quarter
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Market likely to open on flat note amidst dull global cues - The Hindu BusinessLine

Market likely to open on flat note amidst dull global cues June 29, 2021 A view of the Bombay Stock Exchange (file photo)   -  REUTERS× HDFC Life, RITES, Thomas Cook may see action Domestic markets are expected to open on Tuesday on a negative-to-flat note amid weak global cues. As the Union Government announced fresh relief measures to boost economy, experts believe that the market is likely to move in a range with limited downfall. The SGX Nifty is currently ruling at 15,858 indicates (8 am) a flat opening as the Nifty futures on Monday closed at 15,855 and the spot at 15,814.70. The divergent trend continued at the US bourses, with tech-focussed Nasdaq and the broader S&P 500 edging up almost one per cent and 0.23 per cent respectively, even as the Dow Jones Industrial Average slipped 0.44 per cent.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.